$NG
NOVAGOLD RESOURCES INC Stock $ng

$ng Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-Q Financial Statement

#000117184323002135 Filed on April 04, 2023

Income Statement

Concept	2023 Q1	2022 Q1
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$5.606M	$5.175M
YoY Change	8.33%	-2.85%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.000K	$2.000K
YoY Change	-50.0%	0.0%
% of Gross Profit
Operating Expenses	$10.08M	$9.217M
YoY Change	9.38%	26.31%
Operating Profit	-$10.08M	-$9.217M
YoY Change	9.38%	26.31%
Interest Expense	-$5.750M	-$5.028M
YoY Change	14.36%	44.44%
% of Operating Profit
Other Income/Expense, Net	$2.225M	$524.0K
YoY Change	324.62%	-763.29%
Pretax Income	-$10.58M	-$9.995M
YoY Change	5.89%	25.63%
Income Tax	$75.00K	$0.00
% Of Pretax Income
Net Earnings	-$10.66M	-$9.995M
YoY Change	6.64%	25.63%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.03	-$0.03
Diluted Earnings Per Share	-$0.03	-$30.02K
COMMON SHARES
Basic Shares Outstanding	334.0M	333.2M
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$116.2M	$155.1M
YoY Change	-25.12%	35.85%
Cash & Equivalents	$54.16M	$77.13M
Short-Term Investments	$62.00M	$78.00M
Other Short-Term Assets	$2.407M	$1.310M
YoY Change	83.74%	15.32%
Inventory
Prepaid Expenses	$969.0K	$959.0K
Receivables	$339.0K	$351.0K
Other Receivables	$24.93M	$0.00
Total Short-Term Assets	$143.2M	$156.4M
YoY Change	-8.46%	-17.33%
LONG-TERM ASSETS
Property, Plant & Equipment	$911.0K	$369.0K
YoY Change	146.88%	-37.24%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$7.244M	$7.817M
YoY Change	-7.33%	48.81%
Other Assets	$3.038M	$2.714M
YoY Change	11.94%	20.68%
Total Long-Term Assets	$8.155M	$31.97M
YoY Change	-74.49%	11.01%
TOTAL ASSETS
Total Short-Term Assets	$143.2M	$156.4M
Total Long-Term Assets	$8.155M	$31.97M
Total Assets	$151.4M	$188.4M
YoY Change	-19.66%	-13.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$515.0K	$536.0K
YoY Change	-3.92%
Accrued Expenses	$810.0K	$922.0K
YoY Change	-12.15%	9.76%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.474M	$2.298M
YoY Change	7.66%	44.53%
LONG-TERM LIABILITIES
Long-Term Debt	$126.6M	$117.2M
YoY Change	8.01%	5.39%
Other Long-Term Liabilities	$954.0K	$444.0K
YoY Change	114.86%	25.07%
Total Long-Term Liabilities	$954.0K	$444.0K
YoY Change	114.86%	-99.6%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.474M	$2.298M
Total Long-Term Liabilities	$954.0K	$444.0K
Total Liabilities	$130.1M	$120.0M
YoY Change	8.4%	6.01%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.023B	-$1.969B
YoY Change	2.74%	2.21%
Common Stock	$1.985B	$1.981B
YoY Change	0.2%	0.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$21.30M	$68.43M
YoY Change
Total Liabilities & Shareholders Equity	$151.4M	$188.4M
YoY Change	-19.66%	-13.59%

Cashflow Statement

Concept	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$10.66M	-$9.995M
YoY Change	6.64%	25.63%
Depreciation, Depletion And Amortization	$1.000K	$2.000K
YoY Change	-50.0%	0.0%
Cash From Operating Activities	-$4.493M	-$6.003M
YoY Change	-25.15%	40.06%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$5.188M	-$5.936M
YoY Change	-12.6%	-184.15%
Cash From Investing Activities	-$5.188M	-$5.936M
YoY Change	-12.6%	-184.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$0.00	-$2.122M
YoY Change	-100.0%	190.29%
NET CHANGE
Cash From Operating Activities	-$4.493M	-$6.003M
Cash From Investing Activities	-$5.188M	-$5.936M
Cash From Financing Activities	$0.00	-$2.122M
Net Change In Cash	-$9.681M	-$13.99M
YoY Change	-30.81%	-711.76%
FREE CASH FLOW
Cash From Operating Activities	-$4.493M	-$6.003M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001173420
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--11-30
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	us-gaap	Revenues Revenues	0	usd
CY2023Q1	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	24638000	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	24421000	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	1984696000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	84293000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2023167000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-24518000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	21304000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	151361000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5607000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-4475000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-4040000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	10082000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	9217000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-10082000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-9217000	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	2944000	usd
CY2022Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	1512000	usd
CY2023Q1	ng	Notes Receivable Accretion NotesReceivableAccretion	217000	usd
CY2022Q1	ng	Notes Receivable Accretion NotesReceivableAccretion	210000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2225000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	524000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10584000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9995000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	75000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-0	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10659000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-9995000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-101000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	178000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10760000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9817000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	333948
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	332940
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10659000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-9995000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-4475000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-4040000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2161000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2091000	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	2944000	usd
CY2022Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	1512000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	41000	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-112000	usd
CY2023Q1	ng	Notes Receivable Accretion NotesReceivableAccretion	217000	usd
CY2022Q1	ng	Notes Receivable Accretion NotesReceivableAccretion	210000	usd
CY2023Q1	ng	Gain On Sale Of Mineral Property GainOnSaleOfMineralProperty	556000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	299000	usd
CY2023Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	25000	usd
CY2022Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	0	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	2326000	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	3053000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4493000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6003000	usd
CY2023Q1	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	5744000	usd
CY2022Q1	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	5936000	usd
CY2023Q1	ng	Proceeds From Sale Of Mineral Property ProceedsFromSaleOfMineralProperty	556000	usd
CY2022Q1	ng	Proceeds From Sale Of Mineral Property ProceedsFromSaleOfMineralProperty	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5188000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5936000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	-0	usd
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2122000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2122000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-40000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	70000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-9721000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-13991000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	63882000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	91124000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	29903000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2161000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10659000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-101000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	21304000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	78282000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2091000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	0	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	usd
CY2022Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	2122000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-9995000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	178000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-4475000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-4040000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	339000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	301000	usd
CY2023Q1	us-gaap	Interest Receivable Current InterestReceivableCurrent	806000	usd
CY2022Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	62000	usd
CY2023Q1	us-gaap	Accounts Receivable Related Parties AccountsReceivableRelatedParties	293000	usd
CY2022Q4	us-gaap	Accounts Receivable Related Parties AccountsReceivableRelatedParties	574000	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	969000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1298000	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	2407000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2235000	usd
CY2023Q1	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	2127000	usd
CY2022Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	1845000	usd
CY2023Q1	ng	Office Equipment OfficeEquipment	18000	usd
CY2022Q4	ng	Office Equipment OfficeEquipment	19000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3038000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2803000	usd
CY2023Q1	ng	Remediation Current Liabilities RemediationCurrentLiabilities	1149000	usd
CY2022Q4	ng	Remediation Current Liabilities RemediationCurrentLiabilities	1156000	usd
CY2023Q1	ng	Lease Obligations Current LeaseObligationsCurrent	168000	usd
CY2022Q4	ng	Lease Obligations Current LeaseObligationsCurrent	142000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1317000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1298000	usd
CY2023Q1	ng	Remediation Noncurrent Liabilities RemediationNoncurrentLiabilities	200000	usd
CY2022Q4	ng	Remediation Noncurrent Liabilities RemediationNoncurrentLiabilities	200000	usd
CY2023Q1	ng	Lease Obligations Noncurrent LeaseObligationsNoncurrent	754000	usd
CY2022Q4	ng	Lease Obligations Noncurrent LeaseObligationsNoncurrent	802000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	954000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1002000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	2127000	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	1845000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2161000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2091000	usd
CY2023Q1	us-gaap	Salaries And Wages SalariesAndWages	1745000	usd
CY2022Q1	us-gaap	Salaries And Wages SalariesAndWages	1768000	usd
CY2023Q1	us-gaap	Other General Expense OtherGeneralExpense	891000	usd
CY2022Q1	us-gaap	Other General Expense OtherGeneralExpense	729000	usd
CY2023Q1	ng	Corporate Communications And Regulatory Expense CorporateCommunicationsAndRegulatoryExpense	507000	usd
CY2022Q1	ng	Corporate Communications And Regulatory Expense CorporateCommunicationsAndRegulatoryExpense	253000	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	302000	usd
CY2022Q1	us-gaap	Professional Fees ProfessionalFees	334000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	1000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	2000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5607000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5177000	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	1329000	usd
CY2022Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	136000	usd
CY2023Q1	ng	Gain On Sale Of Mineral Property GainOnSaleOfMineralProperty	556000	usd
CY2022Q1	ng	Gain On Sale Of Mineral Property GainOnSaleOfMineralProperty	0	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	41000	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-112000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	299000	usd
CY2022Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	500000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2225000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	524000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2161000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2091000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7717000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.18
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1992000
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.76
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	521000
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.69
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	27000
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	7.76
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9161000
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.21
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y8M12D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4474000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	5346000
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	5.98
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y8M8D
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	4474000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.485	pure
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.464	pure
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0386	pure
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0104	pure
CY2023Q1	ng	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate	0.028	pure
CY2022Q1	ng	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate	0.029	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.43
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.51
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1177000	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1001000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	5894000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	0
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1605000
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	6.89
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested	7281000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	179000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	994000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-250000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-151000	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-1890000	usd
CY2022Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-1908000	usd
CY2023Q1	ng	Increase Decrease In Remediation Liability IncreaseDecreaseInRemediationLiability	-7000	usd
CY2022Q1	ng	Increase Decrease In Remediation Liability IncreaseDecreaseInRemediationLiability	0	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	2326000	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	3053000	usd

Files In Submission

Name	View Source	Status
0001171843-23-002135-index-headers.html	Edgar Link	pending
0001171843-23-002135-index.html	Edgar Link	pending
0001171843-23-002135.txt	Edgar Link	pending
0001171843-23-002135-xbrl.zip	Edgar Link	pending
ex_496258.htm	Edgar Link	pending
ex_496259.htm	Edgar Link	pending
ex_496260.htm	Edgar Link	pending
ex_496261.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
logo.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
ng-20230228.xsd	Edgar Link	pending
ng20230228_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
ng-20230228_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ng-20230228_cal.xml	Edgar Link	unprocessable
ng-20230228_def.xml	Edgar Link	unprocessable
ng-20230228_pre.xml	Edgar Link	unprocessable
ng20230228_10q_htm.xml	Edgar Link	completed
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NG
NOVAGOLD RESOURCES INC Stock $ng

2023 Q1 Form 10-Q Financial Statement

#000117184323002135 Filed on April 04, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NG NOVAGOLD RESOURCES INC Stock $ng

2023 Q1 Form 10-Q Financial Statement

#000117184323002135 Filed on April 04, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NG
NOVAGOLD RESOURCES INC Stock $ng